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Abstract. – Smell loss originates from pe-
ripheral disorders, like intranasal obstruction
and olfactory cell injury, as well as central path-
way diseases. Information derived from electro-
physiological and psychophysical tests are use-
ful for identifying loss of smell, but not for dis-
criminating between central and peripheral
deficits. This is because conventional imaging
modalities are unable to deliver information
about functional olfactory performance. Al-
though functional imaging is able to show ab-
normal changes in central olfactory pathways, it
seems that it is only possible to observe such
abnormalities in olfactory cell dysfunction. We
hypothesize that the scanning of peripheral ol-
factory systems by radiolabeled odor molecules
may specifically reveal olfactory dysfunction
and may be useful for differentiating peripheral
from central olfactory disorders.
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Introduction
Olfactory functions can be disrupted by in-
tranasal obstructions (transport olfactory loss),
destruction of receptors or olfactory cell func-
tions (sensory olfactory loss), and pathological
processes affecting central pathways1. A primary
objective of assessing the impaired sense of
smell is to distinguish an intranasal disorder, in-
cluding olfactory cell injury, from a central
cause. Although, functional imaging such as sin-
gle photon emission computed tomography
(SPECT)2, positron-emission tomography
(PET)3, functional magnetic resonance imaging
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(fMRI)4, is helpful for identifying cerebral hy-
poperfusion in anosmic patient, it seems that it is
incapable of differentiating peripheral from cen-
tral causes5.
We hypothesize that radio-labeling volatile
odor molecules (like vinyl and camphor) are
helpful for the evaluation of olfactory cells and
receptors by isotope scan and may differentiate
olfactory cell disorders from central olfactory
dysfunctions. In addition, radio-labeling volatile
odor molecules may be able to evaluate the de-
gree of injury to olfactory cells. 
Anatomy 
The olfactory receptor cell is a bipolar sensory
neuron with a dendritic knob that extends into
the mucosal cell layer of the nasal cavity and a
thin unmyelinated axon that travels in bundles
through the cribriform plate into the olfactory
bulb. The dendritic knobs bear cilia where odor-
ant transduction occurs. The axons of the first
cranial (olfactory) nerve terminate within the ol-
factory bulb’s glomeruli, where they form synap-
tic contacts with interneurons that have processes
restricted to the bulb, and with output neurons
(mitral and internal tufted cells) that contribute
axons to the lateral olfactory tract6. From the ol-
factory bulb and tract, fibers pass through the ol-
factory stria to septal nuclei. From the medial
and lateral septal nuclei, fibers extend to the lim-
bic system with branches to the uncus, hip-
pocampus, parahippocampal region, septum pel-
lucidum, fornices, amygdala, and gyrus rectus re-
gions6. The nasociliary olfactory nerves, olfacto-
ry bulbs, and olfactory tracts are essential for
odor detection. Disruption in this pathway results
anosmia6. The ability to recognize, interpret, and
remember odors, is located more classically in
the uncus and hippocampus7.
2012; 16: 752-754
Nuclear imaging with radiolabeled odor
molecules in patients with olfactory disorder
M. ASSADI, I. NABIPOUR, R. NEMATI*, H. SALIMIPOUR*,
A. ZAKANI**, M. EFTEKHARI**
The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences,
Bushehr (Iran)
*Department of Neurology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, (Iran)




Olfactory dysfunction is clinically categorized
under peripheral and central causes. The most com-
mon reasons of anosmia are trauma, upper respira-
tory infections, and smoking1. Causes of posttrau-
matic olfactory dysfunction may include: (1) shear-
ing injury of the olfactory nerve axons, (2) brain
contusion and hemorrhage in the olfactory regions,
and (3) sinonasal tract alternation. It is important to
identify the conductive causes of olfactory loss be-
cause they are often reversible through medical or
surgical correction. In 10% of cases, olfactory func-
tion returns, but is reduced (8). The regeneration or
recovery of damaged olfactory neurons may be re-
sponsible for the improvement of olfaction months
after a traumatic injury. Hamsters have demonstrat-
ed that transected olfactory receptor cell axons may
grow through the cribriform plate and reestablish
contact with cells in the olfactory bulb9.
Upper respiratory infection is the most com-
monly identified etiologic cause of anosmia. Al-
though most patients who develop anosmia fol-
lowing upper respiratory infection show no imag-
ing abnormalities, evidence suggests the virus
may damage that olfactory epithelium. Because
these patients developed anosmia following an
upper respiratory infection, the imaging provides
evidence that a viral neuritis may damage the ol-
factory nerves or bulbs10,11. In addition to in-
tracranial abnormalities in congenital anosmia,
abnormalities may also exist in the nasal cavity
neuroepithelium. Thus, this syndrome may be a
central or peripheral cause of anosmia12.
Occupational and accidental exposure to tox-
ins such as acrylates, methacrylates, phosphorus
fire, chlorine gas, oil vapors, solvents, household
cleaners, and airborne cadmium have been linked
to olfactory dysfunction. Such toxins may affect
the peripheral and central toxic central nervous
system. However, it is difficult to differentiate
the ultimate cause in such cases. Imaging in such
cases is frequently used12,13.
Electrophysiologic and Psychophysical Test
Two general types of olfactory testing exist: psy-
chophysical testing (olfactory threshold tests, odor
identification tests) and electrophysiologic testing
(electro-olfactogram [EOG] or odor event–related
potentials [OERPs]). The information derived from
these tests does not allow for differentiation be-
tween central and peripheral deficits. Most olfacto-
ry testing relies on measuring the patient’s detec-
tion thresholds of a specific odorant, or the ability
to identify multiple odorants8.
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Conventional Imaging
Brain CT and MRI have revealed details of
CNS pathology in addition to measurements of
olfactory bulb size and other anatomical struc-
tures in the CNS olfactory system in normal sub-
jects and in patients with hyposmia and impaired
smell of various causes. However, these methods
provided no information about functional olfac-
tory performance2.
Functional Imaging
Several techniques such as PET3, SPECT2, and
functional(fMRI)4 have been proposed for an ob-
jective study of the olfactory pathways. One of the
most widely referenced studies, Levy et al14, found
that brain activation to three different olfactory
stimuli (pyridine, menthone, amylacetate) was
lower in all nine brain sections in anosmic patients
compared with normal subjects. This finding was
particularly strong in the inferior frontal and cingu-
lated gyral regions of the frontal cortex and in the
regions of medial and posterior temporal cortex.
A recent study by Henkin and Levy15 evaluated
the role of fMRI to determine brain activation in
response to olfactory stimulation in patients who
have never had the ability to recognize odors (con-
genital hyposmia). Brain activation in response to
odors was present in patients with congenital hy-
posmia, but the activation was significantly lower
than in normal subjects and patients with acquired
hyposmia. Using quantitative positron emission to-
mography, the study showed that posttraumatic im-
paired smell is closely associated with cerebral
perfusion abnormalities evident in cerebral PET
images16. We showed that patients with posttrau-
matic anosmia exhibit decreased brain activation
compared to normal subjects who experience ol-
factory stimulation. This finding was especially
strong in the orbitofrontal region2,17 which was
confirmed by the following research18. 
In Iran, several nuclear medicine centers rou-
tinely use brain perfusion SPECT for olfactory
assessment. The hypoperfused areas may be due
to the loss of olfactory input to these areas be-
cause of direct and/or contrecoup injury to these
sites5. However, these modalities do not have the
ability to discriminate between peripheral and
central injuries. 
Hypothesis
As discussed above, functional imaging in anos-
mic patients shows hypoperfusion in smell areas.
However, it seems that these methods alone reveal
the existence of perfusion abnormality with a lack
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of high specificity for anosmia and the inability to
detect peripheral origins. We hypothesize that iso-
tope labeling of odors molecules, such as camphor
or vinyl, and the scanning olfactory receptors in the
nasal cavity roof, may be helpful in recognizing ol-
factory cell disorders in the central olfactory path-
way. Furthermore, it may also reveal the severity of
the olfactory cell injury by quantitatively measur-
ing the amount of binding that occurs between the
isotope label and its receptor. This can improve the
specificity for anosmia. 
Clinical Implication 
Olfactory neurons have the capability for neu-
rogenesis, which allows for new receptor growth.
Therefore, it is concluded that the late return of
the function may be associated with a peripheral
(olfactory nerves/ bulbs/tracts) mechanism,
rather than central one. Hamsters have previously
displayed this phenomenon19. If the hypothesis is
proven, it may be helpful for identifying causes
of olfactory dysfunction, and will thus, lead to
better management practices. Moreover, by de-
termining the severity of smell loss, it will pro-
vide a clearly prognosis of the disorder.
Despite occupational medicine’s interest in vi-
sion and hearing, the evaluation of olfaction has
not received adequate attention, which may be due
to a lack of standardized olfactory tests. The prima-
ry olfactory neuron and receptor is the only senso-
ry cell directly in contact with the environment
and, thus, potentially exposed to airborne toxicants.
The olfactory damage reflects the effect of a toxi-
cant on the CNS13. Mascagni et al13 showed that
delayed olfactory improvement in workers could
occur, while the recovery failed in hypersusceptible
workers, who continued to perform poorly in olfac-
tory function. Therefore, in occupational medicine,
this method may useful to evaluate the toxic effect
of environmentally volatile toxicants.
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